Tendler Craig
SEC insider (Form 3/4/5 filer). CIK 0002061924. Director at Parabilis Medicines, Inc. (PBLS) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Aug 22, 2026. Located in CAMBRIDGE, MA.
Companies Tendler Craig has filed insider reports for
- Parabilis Medicines, Inc. (PBLS): Director
- TuHURA Biosciences, Inc./NV (HURA): Director
Tendler Craig
CIK: 0002061924
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Aug 22, 2026PBLS
Parabilis Medicines, Inc.
AwardDirectStock Option (Right to Buy)
20.3K shares- - Feb 12, 2026HURA
TuHURA Biosciences, Inc./NV
AwardDirectOptions (Right to Buy)
156.2K shares- - Mar 10, 2025HURA
TuHURA Biosciences, Inc./NV
AwardDirectOptions (Right to Buy)
151.9K shares-
1-3 of 3 transactions